Patents by Inventor Mary E. Conley

Mary E. Conley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6995914
    Abstract: A method of producing a lenticular sheet having anisotropic optical properties comprising the steps of providing a body of transparent material having a pair of opposing sides and an index of refraction greater than one; forming a plurality of lenses on the first side of said pair of opposing sides in pre-selected portions of the first side; and wherein the remainder of the first side of said pair of opposing sides outside the pre-selected lens portions is generally flat and transparent. A method of manufacturing a lenticular sheet comprising the steps of producing a transparent sheet by engraving a desired lens pattern over an entire cylinder or flat plate; placing a mask over selected lens areas; metal plating the unmasked areas to a thickness greater than the surface of the masked areas; and cutting the plated areas back to the level of the masked areas.
    Type: Grant
    Filed: February 19, 2004
    Date of Patent: February 7, 2006
    Inventors: Kenneth E. Conley, Mary E. Conley, Max B. Smith, Jr., Kerry Dwayne Dellinger
  • Patent number: 5106728
    Abstract: There is provide by the invention a method of diagnosing a human female suspected of being an symptomatic carrier of X-linked agammaglobulinemia (XLA). The method comprises sampling B cell lymphocytes of said female; and determining whether at least 95% of said B cell lymphocytes exhibit inactivation of the same chromosome; whereby said X chromosome inactivation is diagnostic of XLA. The invention further provides a method of screening a human female suspected of being an asymptomatic carrier of X-linked severe combined immunodeficiency (XSCID). The method comprises sampling the B or T cell lymphocytes of said female; determining whether at least 85% of said lymphocytes exhibit inactivation of the same chromosome; whereby said X chromosome inactivation is associated with XSCID.
    Type: Grant
    Filed: March 14, 1990
    Date of Patent: April 21, 1992
    Assignees: Childrens Hospital of Philadelphia, Trustees of the University of Pennsylvania
    Inventors: Mary E. Conley, Robert L. Nussbaum, Jennifer M. Puck